Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Malaria
100%
Plasmodium Falciparum
100%
Pfs25
100%
Gold Nanoparticles
100%
Nanovaccine
100%
Codon
42%
Escherichia Coli
42%
Recombinant
42%
Target Antigen
28%
Blocking Antibodies
28%
Transmission-blocking
28%
Sexual Stage
28%
Immunogenicity
14%
Surface Proteins
14%
Immune Response
14%
Population Level
14%
Disease Burden
14%
Malaria Transmission Blocking
14%
Vaccine Candidate
14%
Phase I Trial
14%
Ookinete
14%
Heterologous Expression System
14%
Endemic Region
14%
Disulfide Bond
14%
Physicochemical Properties
14%
Vaccine Target
14%
Tertiary Structure
14%
Malaria Vaccine
14%
Native Conformation
14%
Zygote
14%
Repeat Motif
14%
Transmission-blocking Vaccine
14%
EGF-like
14%
Size-dependent Properties
14%
Shape Properties
14%
Female Gamete
14%
Pfs230
14%
Homogeneous Products
14%
Highly Potent
14%
Extensive Evaluation
14%
Male Gametocyte
14%
Immunology and Microbiology
Antigen
100%
Plasmodium falciparum
100%
Malaria
100%
Codon
60%
Escherichia coli
60%
Blocking Antibody
40%
Parasite
40%
Immune Response
20%
Immunogenicity
20%
Adjuvant
20%
Ookinete
20%
Gametocyte
20%
Conformation
20%
Gene Expression System
20%
Disulfide Bond
20%
Heterologous Expression
20%
Tertiary Structure
20%
Pharmacology, Toxicology and Pharmaceutical Science